title: [Various parameters of lipid metabolism after intra-arterial injections of ozone in patients with ischemia of the lower extremities and diabetes mellitus].
abstract: In 50 subjects with arteriosclerotic ischaemia of the lower extremities and 41 subjects with diabetes mellitus ozone was applied intra-arterially. Before and after the treatment serum lipids concentration was examined. In the group with arteriosclerotic ischemia significant decrease in cholesterol level and both his fractions was seen. Whereas in the group with diabetes the cholesterol LDL was significantly reduced. In both groups total lipids level serum was decreased. It suggests that ++ozone therapy set back the arteriosclerosis progress, normalized some parameters of lipid metabolism and improved HDL to LDL cholesterol fractions relationship.
authors.affiliation: Katedry i Kliniki Chorób Wewnetrznych i Zawodowych Sl. AM.
authors.forename: J
authors.initials: J
authors.lastname: Sroczyński
authors.forename: Z
authors.initials: Z
authors.lastname: Antoszewski
authors.forename: H
authors.initials: H
authors.lastname: Rudzki
authors.forename: B
authors.initials: B
authors.lastname: Matyszczyk
authors.forename: R
authors.initials: R
authors.lastname: Kuźniewicz
mesh_terms: D000924:Anticholesteremic Agents; D001162:Arteriosclerosis Obliterans / Q000097:blood* / Q000150:complications / Q000188:drug therapy; D008078:Cholesterol, LDL / Q000097:blood*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000150:complications; D003925:Diabetic Angiopathies / Q000097:blood* / Q000150:complications; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy* / Q000209:etiology; D007269:Injections, Intra-Arterial; D007511:Ischemia / Q000097:blood* / Q000188:drug therapy / Q000209:etiology; D007866:Leg / Q000098:blood supply*; D008055:Lipids / Q000097:blood*; D010126:Ozone / Q000008:administration & dosage*
chemical_list: D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D008055:Lipids; D010126:Ozone
vernacular_title: Niektóre parametry gospodarki lipidowej po dotetniczych wstrzyknieciach ozonu u chorych na chorobe niedo-krwienna kończyn dolnych oraz cukrzyce.